Da mindre end 2% af lasofoxifen genfindes i urinen som uomdannet substans, er der ikke foretaget undersøgelser på personer med nyreinsufficiens.
Since less than 2% of lasofoxifene is recovered in urine as unchanged active substance, a study in subjects with renal insufficiency was not conducted.